Ovarian Cancer Articles

Reading about Ovarian Cancer

At GLG Pharma we continue to read and study new and old research that is about ovarian cancer. Many of the articles in this collection were selected by the GLG scientists and scientific advisors. If you would like to see these articles: 

• 2017- Rosso et al-E-cadherin A- A determinant molecule association with Ovarian Cancer

• 2018- Chien et al-Genetic Evidence for Early Peritoneal Spreading in Pelvic High-Grade Serous Cancer
• 2018- Cortez et al-Advances in ovarian cancer therapy
• 2018- Yoshikawa et al-JAK/STAT3 pathway as a therapeutic target in ovarian cancer
• 2019- Lee et al- New Strategies in Ovarian Cancer Treatment
• 2019- Liang et al-Crosstalk STAT3 and p53-RAS in ovarian cancer
• 2020-Izar et al- A single-cell landscape of high-grade serous ovarian cancer
• 2020-Knarr et al- miR-181a initiates and perpetuates oncogenic transformation through the regulation of innate immune signaling
• 2022-Ritch et al- The Transcoelomic Ecosystem and Epithelial Ovarian Cancer Dissemination
• 2022-Sloniwski et al- A Comparative Analysis of Quality of Life in Women Diagnosed with Breast and Ovarian Cancer